Stockreport

Strongbridge Biopharma plc Reports Third Quarter 2019 Financial Results and Provides Corporate Update

Strongbridge Biopharma plc - Ordinary Shares  (SBBP) 
Last strongbridge biopharma plc - ordinary shares earnings: 2/25 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: investors.strongbridgebio.com/investor-overview
PDF ~ KEVEYIS® (dichlorphenamide) Achieved $5.7 Million in Revenue Along with a Positive Contribution Margin in Third Quarter of 2019; Strongbridge Remains On-Track to Meet [Read more]